| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.001 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.4 | 0.004 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.004 |